Parenteral Nutrition Market Trend, Share, Growth, Size and Forecast 2032

Parenteral Nutrition Industry Prospective

The global Parenteral Nutrition market size accrued earnings worth approximately USD 5986.31 Million in 2023 and is predicted to gain revenue of about USD 10,330.46 Million by 2032, is set to record a CAGR of nearly 4.0% over the period from 2024 to 2032.

Request Free Sample

Parenteral Nutrition Market Overview

Parenteral nutrition is an intravenous administration of nutrition solutions to patients. It is used in medical conditions where the functioning of the gastrointestinal tract is obstructed or does not work properly. This leads to the inadequate nourishment of body by enteral or oral means. Many commercial treatments and therapy are available in the markets which are used for different medical conditions. These commercially available premixed solutions effectively provide nutrition for short periods, however in complex patients, personalizing parenteral nutrition is preferred. The wide application of parenteral nutrition in gastrointestinal disorders is driving the growth of global parenteral nutrition market.

Parenteral Nutrition Market Growth Dynamics

The primary reasons for the expected high growth of parenteral nutrition market are the global increase in the incidence of diseases that require parenteral nutrition such as gastrointestinal disorders, malnutrition, cancer, acquired immunodeficiency syndrome, etc. The rise in the elderly population is another reason for market growth, as this group is more prone to chronic diseases and requires more parenteral nutrition support in comparison to the young population. However, the shortage of skilled healthcare professionals and the risk of health complication due to poor monitoring are hampering the growth of parenteral nutrition market. Nonetheless, growing technological innovation in parenteral therapy and rising demand for parenteral nutrition services around the world with a significant rise in parenteral nutrition awareness is expected to offer lucrative opportunities for key players in the forecast period.

Request Free Sample

In order to give the users of this report a comprehensive view of the parenteral nutrition market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

Parenteral Nutrition Market: Report Scope

Parenteral Nutrition Market Segmentation Analysis

The study provides a decisive view of the parenteral nutrition market by segmenting the market based on nutrition type, end-users, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

By nutrient type, the global parenteral nutrition market is divided into carbohydrates, single dose amino acid solution, parenteral lipid emulsion, vitamins and minerals, and trace elements. Single dose amino acid solutions are largely being employed in numerous parenteral therapies. The carbohydrate segment dominated the global parenteral nutrition market, accounting major global revenue share. Single dose amino acid solutions and lipid emulsion were the fastest growing segments. 

Based on the end user segment, the global parenteral nutrition market is segmented into hospitals, clinics, and others. The hospital segment accounted for a maximum share from the end user segment.

Parenteral Nutrition Market Regional Analysis

Based on the geography, the global parenteral nutrition market is divided into five regions North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to remain the dominant region over the forecast period. The growth is due to the presence of technologically advanced medical facilities, the rise in healthcare expenditure, and increasing geriatric population are expected to keep this region in the leading position during the forecast period.

Europe was the second-largest market, followed by the Asia Pacific. Asia Pacific was the fastest growing market with highest CAGR during the forecast period. Developing economies such as India and China is accelerating the growth of this region owing to favorable government initiatives towards development of healthcare infrastructure and heightened corporate investments in the healthcare sector are expected to augment the growth of parenteral nutrition market over the forecast period. The Middle East and Africa and Latin America are expected to experience moderate growth in the parenteral nutrition market in the years to come.

Some of the key players in parenteral nutrition market include

• Baxter International Inc.
• B. Braun Melsungen AG
• Allergan Plc
• Grifols S.A.
• Hospira
• Otsuka Pharmaceutical Factory Inc.
• Fresenius Kabi AG
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Vifor Pharma
• and Aculife Healthcare
• among others.

This report segments the global parenteral nutrition market as follows:

By Nutrient Type Segments

• Carbohydrates
• Parenteral Lipid Emulsion
• Single Dose Amino Acid Solution
• Trace Elements
• Vitamins and Minerals

By End-User Segments

• Hospitals
• Clinics 
• Others

By Regional Segments

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa